NO20031410D0 - Antitumorterapi innbefattende distamycinderivater - Google Patents

Antitumorterapi innbefattende distamycinderivater

Info

Publication number
NO20031410D0
NO20031410D0 NO20031410A NO20031410A NO20031410D0 NO 20031410 D0 NO20031410 D0 NO 20031410D0 NO 20031410 A NO20031410 A NO 20031410A NO 20031410 A NO20031410 A NO 20031410A NO 20031410 D0 NO20031410 D0 NO 20031410D0
Authority
NO
Norway
Prior art keywords
therapy including
antitumor therapy
distamycin derivatives
administration
distamycin
Prior art date
Application number
NO20031410A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031410L (no
Inventor
Camilla Fowst
Franzanne Vreeland
Maria Cristina Rosa Geroni
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20031410L publication Critical patent/NO20031410L/no
Publication of NO20031410D0 publication Critical patent/NO20031410D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20031410A 2000-10-02 2003-03-27 Antitumorterapi innbefattende distamycinderivater NO20031410D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/676,770 US6576612B1 (en) 2000-10-02 2000-10-02 Antitumor therapy comprising distamycin derivatives
PCT/EP2001/010988 WO2002028389A1 (en) 2000-10-02 2001-09-21 Antitumor therapy comprising distamycin derivatives

Publications (2)

Publication Number Publication Date
NO20031410L NO20031410L (no) 2003-03-27
NO20031410D0 true NO20031410D0 (no) 2003-03-27

Family

ID=24715919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031410A NO20031410D0 (no) 2000-10-02 2003-03-27 Antitumorterapi innbefattende distamycinderivater

Country Status (24)

Country Link
US (2) US6576612B1 (zh)
EP (1) EP1345604B1 (zh)
JP (1) JP2004510734A (zh)
KR (1) KR100827560B1 (zh)
CN (1) CN1468099A (zh)
AT (1) ATE339202T1 (zh)
AU (2) AU2002221622B2 (zh)
BR (1) BR0114389A (zh)
CA (1) CA2424116A1 (zh)
CZ (1) CZ299686B6 (zh)
DE (1) DE60123117T2 (zh)
EA (1) EA006295B1 (zh)
EE (1) EE05241B1 (zh)
ES (1) ES2267841T3 (zh)
HU (1) HUP0301247A2 (zh)
IL (1) IL154755A0 (zh)
MX (1) MXPA03002824A (zh)
MY (1) MY134690A (zh)
NO (1) NO20031410D0 (zh)
PE (1) PE20020487A1 (zh)
PL (1) PL363926A1 (zh)
SK (1) SK5032003A3 (zh)
WO (1) WO2002028389A1 (zh)
ZA (1) ZA200303405B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives
US20070249651A1 (en) * 2001-06-20 2007-10-25 Nerviano Medical Sciences S.R.I. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
US6969592B2 (en) * 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
DE60318561T2 (de) * 2002-04-02 2009-01-08 Nerviano Medical Sciences S.R.L., Nerviano Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie
AU2003288263A1 (en) * 2002-10-16 2004-05-04 Pharmacia Italia S.P.A. Use of substituted acrylolyl distamycin derivatives in combination with demethylating agents, in the treatment of cancer
BRPI0520806A2 (pt) * 2005-12-27 2009-06-09 Ct Nac De Investigaciones Oncologicas derivados pirrólicos, processos para a preparação de compostos, seu uso e composição farmacêutica que os contém
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives

Also Published As

Publication number Publication date
MY134690A (en) 2007-12-31
CZ2003909A3 (cs) 2003-08-13
ZA200303405B (en) 2004-05-03
CZ299686B6 (cs) 2008-10-22
EA200300427A1 (ru) 2003-10-30
US20040006023A1 (en) 2004-01-08
NO20031410L (no) 2003-03-27
IL154755A0 (en) 2003-10-31
AU2002221622B2 (en) 2007-05-17
DE60123117D1 (de) 2006-10-26
EA006295B1 (ru) 2005-10-27
CN1468099A (zh) 2004-01-14
MXPA03002824A (es) 2003-07-14
PE20020487A1 (es) 2002-05-23
EE200300129A (et) 2003-06-16
US6576612B1 (en) 2003-06-10
JP2004510734A (ja) 2004-04-08
PL363926A1 (en) 2004-11-29
KR20030096222A (ko) 2003-12-24
US7399748B2 (en) 2008-07-15
ES2267841T3 (es) 2007-03-16
DE60123117T2 (de) 2007-02-08
EP1345604B1 (en) 2006-09-13
ATE339202T1 (de) 2006-10-15
HUP0301247A2 (hu) 2003-09-29
SK5032003A3 (en) 2003-08-05
EE05241B1 (et) 2009-12-15
KR100827560B1 (ko) 2008-05-07
EP1345604A1 (en) 2003-09-24
CA2424116A1 (en) 2002-04-11
BR0114389A (pt) 2004-02-03
AU2162202A (en) 2002-04-15
WO2002028389A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
EG25822A (en) Quinolinyl-pyrrolopyrazoles
PT1017675E (pt) Derivados da camtotecina altamente lipofilos
EA200100954A1 (ru) Производные камптотецина, обладающие противоопухолевой активностью
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
SE0101932D0 (sv) Pharmaceutical combinations
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
EE200100066A (et) Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
SE9602262D0 (sv) New use of derivatives of cystine
AR033579A1 (es) Terapia antitumoral que comprende derivados de distamicina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application